Addex Therapeutics (ADXN) Operating Leases (2022 - 2025)
Historic Operating Leases for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $36207.2.
- Addex Therapeutics' Operating Leases fell 1417.78% to $36207.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $36207.2, marking a year-over-year decrease of 1417.78%. This contributed to the annual value of $39429.9 for FY2024, which is 8971.57% down from last year.
- Per Addex Therapeutics' latest filing, its Operating Leases stood at $36207.2 for Q3 2025, which was down 1417.78% from $37319.0 recorded in Q2 2025.
- Over the past 5 years, Addex Therapeutics' Operating Leases peaked at $3.8 million during Q1 2024, and registered a low of $21883.7 during Q2 2024.
- Its 4-year average for Operating Leases is $360236.0, with a median of $42188.6 in 2024.
- As far as peak fluctuations go, Addex Therapeutics' Operating Leases soared by 960188.38% in 2024, and later crashed by 9904.26% in 2025.
- Over the past 4 years, Addex Therapeutics' Operating Leases (Quarter) stood at $387322.2 in 2022, then grew by 0.22% to $388188.7 in 2023, then tumbled by 89.8% to $39597.1 in 2024, then fell by 8.56% to $36207.2 in 2025.
- Its Operating Leases was $36207.2 in Q3 2025, compared to $37319.0 in Q2 2025 and $36486.3 in Q1 2025.